Insulin Aspart
- TRADE NAMES: NovoLog (Novo Nordisk); NovoRapid (Novo Nordisk); Ryzodeg (Novo Nordisk)
- INDICATIONS: Diabetes mellitus
- CLASS: Hormone, polypeptide
- HALF-LIFE: 81 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Alcohol, Atypical antipsychotics, Beta blockers, Clonidine, Corticosteroids, Danazol, Disopyramide, Diuretics, Epinephrine, Estrogens, Fibrates, Fluoxetine, Isoniazid, Isoniazid, Lithium salts, MAO inhibitors, Niacin, Octreotide, Oral Contraceptives, Pentamidine, Phenothiazine derivatives, Pramlintide, Propoxyphene, Salbutamol, Salicylates, Somatropin, Sulfonamide antibiotics, Terbutaline, Thyroid hormones
PREGNANCY CATEGORY: B
Ryzodeg is insulin aspart and insulin degludec; various forms of insulin are available - see other insulin profiles for reaction details.
Please login to see the rest of this drug profile
SKIN.
NAILS.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric